Clinical trial

Hypospadias and Exome: Identification of New Genes for Familial Hypospadias

Name
9477
Description
Hypospadias is the second most common malformation of the male genitalia and consists in a congenital hypoplasia of its ventral face. Hypospadias results from abnormal development of the penis that leaves the urethral meatus proximal to its normal glanular position. Meatus position may be located anywhere along the penile shaft, but more severe forms of hypospadias may have a urethral meatus located at the scrotum or perineum. Glandular and penile anterior represents approximately 70% of all the diagnosed cases. The frequency of family reached depend on the severity of hypospadias. The number of children which have hypospadias mutation discovered by classical technique is low. Families are often the cause of the discovery of new genes involved in sexual differentiation because they allow comparison of genomes of related persons, and detect more easily mutations.
Trial arms
Trial start
2014-11-13
Estimated PCD
2015-11-12
Trial end
2024-04-24
Status
Completed
Treatment
Exome sequencing
Plain DNA sequencing
Arms:
Hypospadias
Size
60
Primary endpoint
number of new genetic variants
1 day
Eligibility criteria
Inclusion Criteria: * Hypospadiac patients with a familial history of hypospadias Exclusion Criteria: * Hypospadiac patients without a family history of hypospadias * Hypospadiac patients with a family history of hypospadias where etiology is identified
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'primaryPurpose': 'DIAGNOSTIC', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 60, 'type': 'ACTUAL'}}
Updated at
2024-04-25

1 organization

1 product

1 indication

Indication
Hypospadias